Published in Br J Cancer on June 01, 1999
Testosterone treatment is a potent tumor promoter for the rat prostate. Endocrinology (2014) 2.14
The UGT2B17 gene deletion polymorphism and risk of prostate cancer. A case-control study in Caucasians. Cancer Detect Prev (2007) 1.69
Genetic variation in the HSD17B1 gene and risk of prostate cancer. PLoS Genet (2005) 1.67
Sex hormones and the risk of incident prostate cancer. Urology (2010) 1.52
Risk factors for prostate cancer. Nat Clin Pract Urol (2009) 1.03
Sex steroids and prostate carcinogenesis: integrated, multifactorial working hypothesis. Ann N Y Acad Sci (2006) 1.02
Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control study. Cancer Causes Control (2011) 0.98
A prospective study of lifetime physical activity and prostate cancer incidence and mortality. Br J Cancer (2009) 0.94
Prolactin regulation of the prostate gland: a female player in a male game. Nat Rev Urol (2011) 0.90
Hormones and diet: low insulin-like growth factor-I but normal bioavailable androgens in vegan men. Br J Cancer (2000) 0.88
Repeat polymorphisms in estrogen metabolism genes and prostate cancer risk: results from the Prostate Cancer Prevention Trial. Carcinogenesis (2011) 0.87
Hormones and prostate carcinogenesis: Androgens and estrogens. J Carcinog (2011) 0.86
A perspective on the role of estrogen in hormone-induced prostate carcinogenesis. Cancer Lett (2012) 0.85
Significance of Serum Testosterone for Prostate-Specific Antigen (PSA) Elevation and Prediction of Prostate Cancer in Patients with PSA Above 10 ng/ml. Korean J Urol (2010) 0.84
The role of estrogens in prostate carcinogenesis: a rationale for chemoprevention. Rev Urol (2005) 0.84
Epidemiological study of prostate cancer (EPICAP): a population-based case-control study in France. BMC Cancer (2014) 0.77
Characterization of SV-40 Tag rats as a model to study prostate cancer. BMC Cancer (2009) 0.77
A Perspective on Prostate Carcinogenesis and Chemoprevention. Curr Pharmacol Rep (2015) 0.76
Sex Steroid Hormone Single-Nucleotide Polymorphisms, Pesticide Use, and the Risk of Prostate Cancer: A Nested Case-Control Study within the Agricultural Health Study. Front Oncol (2016) 0.75
[Epidemiological evidence for preventing prostate cancer by physical activity]. Wien Med Wochenschr (2012) 0.75
Cancer statistics, 1996. CA Cancer J Clin (1996) 6.85
Prospective study of sex hormone levels and risk of prostate cancer. J Natl Cancer Inst (1996) 4.66
Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer (1991) 3.14
Latent carcinoma of prostate at autopsy in seven areas. The International Agency for Research on Cancer, Lyons, France. Int J Cancer (1977) 2.56
Serum testosterone levels in healthy young black and white men. J Natl Cancer Inst (1986) 2.27
5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet (1992) 1.77
Western diet and Western diseases: some hormonal and biochemical mechanisms and associations. Scand J Clin Lab Invest Suppl (1990) 1.75
The early in utero oestrogen and testosterone environment of blacks and whites: potential effects on male offspring. Br J Cancer (1988) 1.66
Prostate cancer: a current perspective. Epidemiol Rev (1991) 1.61
Endogenous estrogen and postmenopausal breast cancer: a quantitative review. Cancer Causes Control (1997) 1.38
Representativeness of a single point plasma testosterone level for the long term hormonal milieu in men. J Clin Endocrinol Metab (1992) 1.28
A prospective, population-based study of androstenedione, estrogens, and prostatic cancer. Cancer Res (1990) 1.14
Genetic variability of the human SRD5A2 gene: implications for prostate cancer risk. Cancer Res (1995) 1.14
Relationships of serum androgens and estrogens to prostate cancer risk: results from a prospective study in Finland. Cancer Epidemiol Biomarkers Prev (1998) 1.11
Review of the role of androgenic hormones in the epidemiology of benign prostatic hyperplasia and prostate cancer. Urology (1994) 1.07
Serological precursors of cancer: serum hormones and risk of subsequent prostate cancer. Cancer Epidemiol Biomarkers Prev (1993) 1.05
Genetic variation of 3 beta-hydroxysteroid dehydrogenase type II in three racial/ethnic groups: implications for prostate cancer risk. Prostate (1997) 1.00
Prediagnostic serum hormones and the risk of prostate cancer. Cancer Res (1988) 0.96
Longitudinal evaluation of serum androgen levels in men with and without prostate cancer. Prostate (1995) 0.94
Androgens in serum and the risk of prostate cancer: a nested case-control study from the Janus serum bank in Norway. Cancer Epidemiol Biomarkers Prev (1997) 0.92
Serum androgens and prostate cancer. Cancer Epidemiol Biomarkers Prev (1996) 0.84
5 alpha-reductase activity and prostate cancer: a case-control study using stored sera. Cancer Epidemiol Biomarkers Prev (1997) 0.81
The relationship of serum dehydroepiandrosterone and its sulfate to subsequent cancer of the prostate. Cancer Epidemiol Biomarkers Prev (1993) 0.80
Case-control studies of selected hormones and prostate cancer. An epidemiologic review. Ala J Med Sci (1986) 0.79
European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr (2002) 8.77
Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst (2003) 6.20
Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab (1998) 4.63
Comparison of dietary assessment methods in nutritional epidemiology: weighed records v. 24 h recalls, food-frequency questionnaires and estimated-diet records. Br J Nutr (1994) 4.32
Validation of dietary assessment methods in the UK arm of EPIC using weighed records, and 24-hour urinary nitrogen and potassium and serum vitamin C and carotenoids as biomarkers. Int J Epidemiol (1997) 3.79
Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer (2005) 3.04
Shift work and chronic disease: the epidemiological evidence. Occup Med (Lond) (2011) 2.93
Mortality in vegetarians and nonvegetarians: detailed findings from a collaborative analysis of 5 prospective studies. Am J Clin Nutr (1999) 2.78
Dietary habits and mortality in 11,000 vegetarians and health conscious people: results of a 17 year follow up. BMJ (1996) 2.61
Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study. Diabetologia (2011) 2.43
Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies. Br J Cancer (2011) 2.20
Validation of weighed records and other methods of dietary assessment using the 24 h urine nitrogen technique and other biological markers. Br J Nutr (1995) 2.07
Circulating levels of sex hormones and their relation to risk factors for breast cancer: a cross-sectional study in 1092 pre- and postmenopausal women (United Kingdom). Cancer Causes Control (2001) 2.07
Lessons of Chernobyl. BMJ (1991) 1.98
Consumption of sweet beverages and type 2 diabetes incidence in European adults: results from EPIC-InterAct. Diabetologia (2013) 1.93
Dietary determinants of ischaemic heart disease in health conscious individuals. Heart (1997) 1.87
Cancer in the Ukraine, post-Chernobyl. Lancet (1991) 1.82
The Oxford Vegetarian Study: an overview. Am J Clin Nutr (1999) 1.75
DNA repair polymorphisms and cancer risk in non-smokers in a cohort study. Carcinogenesis (2005) 1.54
Soya foods and breast cancer risk: a prospective study in Hiroshima and Nagasaki, Japan. Br J Cancer (1999) 1.53
Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study. J Thromb Haemost (2012) 1.52
Fruit and vegetable intake and type 2 diabetes: EPIC-InterAct prospective study and meta-analysis. Eur J Clin Nutr (2012) 1.46
Sex hormone binding globulin and risk factors for breast cancer in a population of normal women who had never used exogenous sex hormones. Br J Cancer (1987) 1.44
Long-term weight change and breast cancer risk: the European prospective investigation into cancer and nutrition (EPIC). Br J Cancer (2005) 1.44
Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies. Lancet Oncol (2013) 1.43
A prospective study of serum insulin-like growth factor-I (IGF-I), IGF-II, IGF-binding protein-3 and breast cancer risk. Br J Cancer (2005) 1.40
Mediterranean diet and type 2 diabetes risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study: the InterAct project. Diabetes Care (2011) 1.39
Diet and body mass index in 38000 EPIC-Oxford meat-eaters, fish-eaters, vegetarians and vegans. Int J Obes Relat Metab Disord (2003) 1.39
Animal foods, protein, calcium and prostate cancer risk: the European Prospective Investigation into Cancer and Nutrition. Br J Cancer (2008) 1.38
Endogenous estrogen and postmenopausal breast cancer: a quantitative review. Cancer Causes Control (1997) 1.38
Plasma carotenoids as biomarkers of intake of fruits and vegetables: individual-level correlations in the European Prospective Investigation into Cancer and Nutrition (EPIC). Eur J Clin Nutr (2005) 1.36
Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study. Br J Cancer (2006) 1.34
A case-control study of diet and prostate cancer. Br J Cancer (1997) 1.32
Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition. Br J Cancer (2011) 1.27
Nutrition, lifestyle and colorectal cancer incidence: a prospective investigation of 10998 vegetarians and non-vegetarians in the United Kingdom. Br J Cancer (2004) 1.27
A prospective study of endogenous serum hormone concentrations and breast cancer risk in post-menopausal women on the island of Guernsey. Br J Cancer (1997) 1.26
A prospective study of endogenous serum hormone concentrations and breast cancer risk in premenopausal women on the island of Guernsey. Br J Cancer (1997) 1.25
A case-control study of dietary carotene in men with lung cancer and in men with other epithelial cancers. Nutr Cancer (1991) 1.21
Low body mass index in non-meat eaters: the possible roles of animal fat, dietary fibre and alcohol. Int J Obes Relat Metab Disord (1998) 1.20
Cancer incidence in British vegetarians. Br J Cancer (2009) 1.19
A cross-sectional analysis of physical activity and obesity indicators in European participants of the EPIC-PANACEA study. Int J Obes (Lond) (2009) 1.18
Physical activity reduces the risk of incident type 2 diabetes in general and in abdominally lean and obese men and women: the EPIC-InterAct Study. Diabetologia (2012) 1.17
Cytokine gene polymorphisms and the risk of adenocarcinoma of the stomach in the European prospective investigation into cancer and nutrition (EPIC-EURGAST). Ann Oncol (2008) 1.16
Mortality in vegetarians and non-vegetarians: a collaborative analysis of 8300 deaths among 76,000 men and women in five prospective studies. Public Health Nutr (1998) 1.14
Diet, serum insulin-like growth factor-I and IGF-binding protein-3 in European women. Eur J Clin Nutr (2006) 1.10
Adherence to the mediterranean diet and risk of breast cancer in the European prospective investigation into cancer and nutrition cohort study. Int J Cancer (2012) 1.10
Persistent effects of women's parity and breastfeeding patterns on their body mass index: results from the Million Women Study. Int J Obes (Lond) (2012) 1.09
Alcohol drinking, tobacco smoking and subtypes of haematological malignancy in the UK Million Women Study. Br J Cancer (2012) 1.05
Genetic susceptibility according to three metabolic pathways in cancers of the lung and bladder and in myeloid leukemias in nonsmokers. Ann Oncol (2007) 1.05
Variety in vegetable and fruit consumption and the risk of gastric and esophageal cancer in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer (2012) 1.05
Fruits and vegetables consumption and the risk of histological subtypes of lung cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Causes Control (2010) 1.02
Plasma phyto-oestrogens and prostate cancer in the European Prospective Investigation into Cancer and Nutrition. Br J Cancer (2009) 1.02
Oral contraceptives, reproductive history and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition. Br J Cancer (2010) 1.01
Smoking and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition. Br J Cancer (2012) 1.01
Quantitative analysis of DNA methylation after whole bisulfitome amplification of a minute amount of DNA from body fluids. Epigenetics (2009) 1.00
Primary brain tumours and specific serum immunoglobulin E: a case-control study nested in the European Prospective Investigation into Cancer and Nutrition cohort. Allergy (2011) 1.00
Re: Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. J Natl Cancer Inst (1997) 0.98
Health benefits of a vegetarian diet. Proc Nutr Soc (1999) 0.96
Total dietary carbohydrate, sugar, starch and fibre intakes in the European Prospective Investigation into Cancer and Nutrition. Eur J Clin Nutr (2009) 0.96
Relation between body mass index and mortality in an unusually slim cohort. J Epidemiol Community Health (2003) 0.95
A case--control study of selenium in nails and prostate cancer risk in British men. Br J Cancer (2004) 0.94
The association between polymorphisms in the CYP17 and 5alpha-reductase (SRD5A2) genes and serum androgen concentrations in men. Cancer Epidemiol Biomarkers Prev (2001) 0.92
Preliminary survival analysis of UK AIDS data. Lancet (1988) 0.91
Consumption of fish and meats and risk of hepatocellular carcinoma: the European Prospective Investigation into Cancer and Nutrition (EPIC). Ann Oncol (2013) 0.90
Postmenopausal endometrial cancer risk and body size in early life and middle age: prospective cohort study. Br J Cancer (2012) 0.89
Pregnancy and menstrual hormone levels in mothers of twins compared to mothers of singletons. Ann Hum Biol (1998) 0.89
Hormones and diet: low insulin-like growth factor-I but normal bioavailable androgens in vegan men. Br J Cancer (2000) 0.88
LHRH agonists and the prevention of breast and ovarian cancer. Br J Cancer (1989) 0.88
Alcohol consumption and risk of type 2 diabetes in European men and women: influence of beverage type and body size The EPIC-InterAct study. J Intern Med (2012) 0.88
Serum concentrations of vitamin B12 and folate in British male omnivores, vegetarians and vegans: results from a cross-sectional analysis of the EPIC-Oxford cohort study. Eur J Clin Nutr (2010) 0.87
Dietary beta-carotene, vitamin C and E intake and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Breast Cancer Res Treat (2009) 0.86
Soy milk intake and plasma sex hormones: a cross-sectional study in pre- and postmenopausal women (EPIC-Oxford). Nutr Cancer (2001) 0.84
Adherence to the Mediterranean diet and risk of bladder cancer in the EPIC cohort study. Int J Cancer (2013) 0.84
Meat intake and bladder cancer in a prospective study: a role for heterocyclic aromatic amines? Cancer Causes Control (2008) 0.84
Mortality and fresh fruit consumption. IARC Sci Publ (2002) 0.83
Endogenous hormones and the aetiology of breast cancer. Breast Cancer Res (1999) 0.82
A prospective study of serum bile acid concentrations and colorectal cancer risk in post-menopausal women on the island of Guernsey. Br J Cancer (2002) 0.82
Vitamin C intake from diary recordings and risk of breast cancer in the UK Dietary Cohort Consortium. Eur J Clin Nutr (2011) 0.81
Blood pressure, plasma renin activity and aldosterone concentrations in vegans and omnivore controls. Hum Nutr Appl Nutr (1987) 0.81
Dietary fibre intake and ischaemic heart disease mortality: the European Prospective Investigation into Cancer and Nutrition-Heart study. Eur J Clin Nutr (2012) 0.81
Glycemic index, hyperinsulinemia, and breast cancer risk. Ann Oncol (2001) 0.81